Vanda Pharmaceuticals - Smith-Magenis Syndrome Patient Registry

Sign up to stay informed on the latest updates regarding Smith-Magenis Syndrome (SMS) and sleep disturbances.

The registry connects you with information about future research opportunities and shares information about sleep problems associated with SMS. You will also have an opportunity to sign up to receive helpful tools, learn about resources, and be invited to special educational events.

To learn more, please visit: www.SMSVandaRegistry.com, or call 855-798-2632


Vanda Pharmaceuticals Clinical Trial

Clinical Trial Recruitment

Announcing an upcoming study in people with Smith-Magenis Syndrome who have disrupted sleeping patterns.

A new clinical study is being conducted to evaluate an investigational treatment for the sleep disturbances in people with Smith-Magenis Syndrome (SMS).

We are looking for parents or guardians of individuals with SMS who are over the age of 16 and who have disrupted sleeping patterns.

Participants may qualify if they:

  • Are between the ages of 16 - 65
  • Have Smith-Magenis Syndrome
  • Have sleeping problems

Qualified individuals and their guardians will be compensated for their time and effort. Transportation will be provided at no cost.

For more information, contact 301-654-5665 or email This email address is being protected from spambots. You need JavaScript enabled to view it..